期刊
INTERNAL MEDICINE JOURNAL
卷 47, 期 6, 页码 701-704出版社
WILEY
DOI: 10.1111/imj.13442
关键词
diabetic ketoacidosis; diabetes mellitus; type 2; sodium-glucose transporter 2; hypoglycaemic agents; humans
Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are an increasingly prescribed class of medication for type 2 diabetes mellitus. Euglycaemic diabetic ketoacidosis (euDKA) has been reported in association with SGLT2i use. Clinicians need to understand how to recognise and treat this complication. We describe three cases of euDKA in patients treated with SGLT2i.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据